Skip to main content
TipRanks
Go Ultimate75% OFF

Christopher Liu Profile - Lucid Capital Analyst

46 Followers

Christopher Liu's Stock Coverage

NVCT
Nuvectis Pharma
Aug 05, 2026BUYReiterated$34.003Ratings100%+19.43%
CRDF
Cardiff Oncology
Jun 05, 2026BUYReiterated$4.002Ratings0%-44.45%
NXTC
NextCure
Jun 02, 2026BUYReiterated$25.002Ratings50%+36.45%
FTH
Faeth Therapeutics
May 28, 2026BUYInitiated$50.001Ratings0%-50.40%
ACTU
Actuate Therapeutics, Inc.
May 18, 2026BUYReiterated$5.001Ratings0%-89.90%
RLMD
Relmada Therapeutics
Mar 02, 2026BUYInitiated$14.001Ratings0%-41.00%
TVRD
Tvardi Therapeutics
Feb 04, 2026BUYUpgraded$6.002Ratings0%-73.00%
ANL
Adlai Nortye Ltd. Sponsored ADR
Jan 29, 2026BUYInitiated$11.001Ratings100%+33.80%
AAPG
Ascentage Pharma Group International Unsponsored ADR
Dec 15, 2025BUYInitiated$50.001Ratings0%-52.80%
IPHA
Innate Pharma
Oct 23, 2025BUYInitiated$8.001Ratings0%-31.50%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Christopher Liu activity FAQ

What is the performance of Christopher Liu's recommendations?
The percentage of profitable recommendations made by Christopher Liu is 41.35%, and the average return per transaction is 5.80%.
What stocks does Christopher Liu cover?
Christopher Liu mostly covers Nuvectis Pharma, Cardiff Oncology, NextCure stocks.
What was Christopher Liu's most profitable rating?
Christopher Liu’s most profitable rating was a buy on Nurix Therapeutics stock on Nov 02, 2023. The return on the trade was 340.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here